SIR-Spheres Activity Measurements Reveal Systematic Miscalibration | Journal of Nuclear Medicine
Sirtex - About SIR-Spheres
SIROS System for Advanced SIR-Spheres® Resin Microspheres Delivery Launched – Medical Device News Magazine
What are SIR-Spheres?
South African health insurer approves reimbursement of SIR-Spheres Y-90 resin microspheres for patients with liver tumours - Interventional News
SIR-Spheres® Y-90 Resin Microspheres Obtains Recommendation from NICE and Approval from the FDA to Conduct Clinical Trials on Primary Liver Cancer - Corporate News - News Center - Grand Pharmaceutical Group Limited
Delivery Box Set Up for SIR-Spheres Y-90 resin microspheres - YouTube
SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers | Hepatic Oncology
Sirtex - Nuclear Medicine
Y-90 SIR-Spheres Treatment of Unresectable Primary or Metastatic Liver Tumors
Sirtex - About SIR-Spheres
Elliot Hospital | SIRT Selective Internal radiation Therapy
SIR-Spheres® Y-90 Microsphere Injection - Intervention, Nuclear Medicine and Immunotherapy for Anti-tumor - Product Center - Grand Pharmaceutical Group Limited
Patient Selection for SIR-Spheres Y-90 resin microspheres - YouTube
Comments about the SIRTeX Medical SIR-Spheres Y90 Resin Microspheres
SIR-Spheres Y-90 resin microspheres Mode of Action Video - YouTube
SIR-Spheres Microspheres for the Treatment of Liver Mets From CRC: Results of the SIRFLOX Trial Eagerly Anticipated
SIR-Spheres with chemotherapy can prolong progression-free survival in colorectal cancer of the liver - Interventional News
SIR-Spheres® Y-90 Resin Microspheres
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
New Jersey Liver & Pancreas Surgery
SIR-Spheres® Y-90 Microspheres – Global Medical Solutions - Nuclear Supplies
